These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 29212576)
1. The Effects of Physical Exercise on Fatty Liver Disease. van der Windt DJ; Sud V; Zhang H; Tsung A; Huang H Gene Expr; 2018 May; 18(2):89-101. PubMed ID: 29212576 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review. Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220 [TBL] [Abstract][Full Text] [Related]
3. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541 [TBL] [Abstract][Full Text] [Related]
4. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Sugimoto K; Inui H; Fukusato T World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263 [TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. Kwak MS; Kim D Korean J Intern Med; 2018 Jan; 33(1):64-74. PubMed ID: 29202557 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. Farzanegi P; Dana A; Ebrahimpoor Z; Asadi M; Azarbayjani MA Eur J Sport Sci; 2019 Aug; 19(7):994-1003. PubMed ID: 30732555 [TBL] [Abstract][Full Text] [Related]
7. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
8. Irisin, a link among fatty liver disease, physical inactivity and insulin resistance. Arias-Loste MT; Ranchal I; Romero-Gómez M; Crespo J Int J Mol Sci; 2014 Dec; 15(12):23163-78. PubMed ID: 25514415 [TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Samuel VT; Shulman GI Cell Metab; 2018 Jan; 27(1):22-41. PubMed ID: 28867301 [TBL] [Abstract][Full Text] [Related]
14. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial]. Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360 [No Abstract] [Full Text] [Related]
15. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817 [TBL] [Abstract][Full Text] [Related]
16. Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study. Pfirrmann D; Huber Y; Schattenberg JM; Simon P J Med Internet Res; 2019 Jan; 21(1):e11250. PubMed ID: 30602434 [TBL] [Abstract][Full Text] [Related]
17. Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease. Guo R; Liong EC; So KF; Fung ML; Tipoe GL Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):139-44. PubMed ID: 25865685 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431 [TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. Milic S; Mikolasevic I; Krznaric-Zrnic I; Stanic M; Poropat G; Stimac D; Vlahovic-Palcevski V; Orlic L Drug Des Devel Ther; 2015; 9():4835-45. PubMed ID: 26316717 [TBL] [Abstract][Full Text] [Related]
20. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Liu J; Xu Y; Hu Y; Wang G Metabolism; 2015 Mar; 64(3):380-90. PubMed ID: 25516477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]